Clinical Trials Browser

Phase 1 × Completed × Solid Tumor × Clear all

NCT05162755 2026-05-12

S095029 as Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triple Combinations in Patients With Metastatic Gastric or Colorectal Cancers

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT07554196 2026-04-28

A Phase 1 Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HH-101 in Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04158336 2026-03-18

A Study of Azenosertib (ZN-c3) in Participants With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05735366 2026-03-10

A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04617314 2026-01-06

A Study of RC108-ADC in Subjects With Advanced Malignant Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05322408 2025-11-05

HCW9218 in Select Advanced Solid Tumors

Phase 1 Completed

18 enrolled 17 charts

Other solid neoplasm

Solid Tumor

NCT05109832 2025-09-16

A Study of Absorption-Distribution-Metabolism-Excretion (ADME) of [14C]IMP4297 to China Healthy Male Subjects

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05390944 2025-09-16

An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fasting Condition

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05391048 2025-09-16

An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fed Condition

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05989997 2025-09-16

Phase I Clinical Trial of 68Ga-NOTA-SNA002

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04937153 2025-07-16

GEN1046 Safety and PK in Subjects With Advanced Solid Malignancies

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT06443710 2025-07-15

Technetium [99mTc]-H7ND in Patients With Gastrointestinal Malignancies and Healthy Volunteers

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05323045 2025-07-09

A First-in-human Dose-escalation and Expansion Study With the Antibody-drug Conjugate BYON3521

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT07030439 2025-06-22

A Bioequivalence Study to Compare Senaparib Manufactured at 2 Sites in Healthy Subjects in Fasting State

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT07019194 2025-06-13

An Bioequivalence Study to Compare 10mg & 20mg of Senaparib Capsules in Healthy Chinese Subjects Under Fasting Condition

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT02454010 2025-04-04

A Dose Escalation Study of Radio-labeled Antibody for the Treatment of Advanced Cancer

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT01585623 2025-03-05

Drug Interaction Study of SAR302503 in Patients With Solid Tumor

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT06258330 2025-01-28

Study of AM003 in Patients With Locally Advanced and Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05176509 2025-01-06

A Study to Evaluate the Combination of YH003, YH001 and Pembrolizumab in Subjects with Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05357820 2024-11-21

A Study of AB-106 in Chinese Healthy Adult Men Evaluated the Effects of Itraconazole and Rifampicin on AB-106 PK

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05357911 2024-11-21

A Study on the Effect of AB-106 on the Pharmacokinetics of Digoxin

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT03994211 2024-10-26

Study to Investigate the Effect of Rifampin and Itraconazole on the Action of Pamiparib in Participants With Cancer

Phase 1 Completed

25 enrolled 33 charts

Other solid neoplasm

Solid Tumor

NCT04366648 2024-09-04

Safety, Tolerability and Pharmacokinetics of Injectable PEG-Irinotecan (JK-1201I) in Patients with Malignant Solid Tumor

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05088070 2024-08-30

Clinical Study of SPH3348 Tablets, a C-Met Inhibitor, in Patients with Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04410224 2024-07-10

ASN004

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04403308 2024-05-03

ONO-7913 Phase I Study (ONO-7913)

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT00921336 2024-04-25

Safety Study to Evaluate KW-2450 in Subjects With Advanced Solid Tumor

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05173792 2024-04-25

Study of AK119 in Subjects With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04557306 2024-04-08

Evaluationn of Tolerability and Safety of CBT101, an Autologous Natural Killer Cell, in Patients With Solid Cancer

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05547906 2024-03-13

Evaluation of the Safety and Efficacy of ASCA101 in Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05248074 2024-02-20

To Evaluate the Safety, Pharmacokinetic and the Effect of Food After Administration of ABN401 in Healthy Adult Volunteers

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04862767 2024-01-31

TASO-001 in Combination With Recombinant Interleukin-2(Aldesleukin) in Advanced or Metastatic Solid Tumor

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04235101 2024-01-05

Phase I Study of SYD985 With Niraparib in Patients With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04475523 2023-10-27

Phase 1 Study of CI-8993 Anti-VISTA Antibody in Patients With Advanced Solid Tumor Malignancies

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT03099109 2023-10-17

A Study of LY3321367 Alone or With LY3300054 in Participants With Advanced Relapsed/Refractory Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT02718911 2023-10-16

A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors

Phase 1 Completed

72 enrolled 23 charts

Other solid neoplasm

Solid Tumor

NCT02959619 2023-08-21

Ensartinib in Non-small Cell Lung Cancer Patients With Positive ALK

Phase 1 Completed

Other solid neoplasmThoracic

Solid Tumor

NCT03990454 2023-08-18

Safety Study of SLC-391 in Subjects With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05119998 2023-08-18

A Phase I Study of IBI325 in Patients With Advanced Solid Tumor

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT02986100 2023-06-09

AME

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05046808 2023-06-08

Pharmacokinetics Study of Famitinib Malate Capsules in Healthy Subjects

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05336279 2023-05-18

Bioequivalence Study of Famitinib Malate in Healthy Volunteers Under Fasting Condition

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT02278250 2023-03-16

First in Human Study of M4344 in Participants With Advanced Solid Tumors

Phase 1 Completed

97 enrolled 77 charts

Other solid neoplasm

Solid Tumor

NCT04547205 2023-02-23

A Study of Anti-VEGFR2 AK109 in Subjects With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05230290 2023-02-06

Clinical Study of KD6001 in Advanced Solid Tumours

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04202705 2023-01-30

A First-in-human Dose-escalation and Expansion Study With the Antibody-drug Conjugate SYD1875

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT03051477 2022-12-08

Trial of Mistletoe Extract in Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05440006 2022-09-08

A Study of Food Effect on the Pharmacokinetics of Fuzuloparib Capsules in Chinese Healthy Adult Subjects

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT03642834 2022-07-06

Study of ICP-105 in Solid Tumors Patients

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT03916094 2022-05-05

Evaluate Safety, Tolerability and Pharmacokinetics of HLX22 in Patients With Advanced Solid Tumors Overexpressing HER2

Phase 1 Completed

Other solid neoplasm

Solid Tumor